# Chemed Corp (CHE) Stock Analysis: Healthcare Service Leader Eyes 16.85% Potential Upside

- Link: https://www.directorstalkinterviews.com/chemed-corp-che-stock-analysis-healthcare-service-leader-eyes-16-85-potential-upside/4121241161
- Published: 2026-02-23T11:28:02+00:00
- Author: Madison Wilson

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, is drawing
investor attention with its robust service offerings and a notable potential upside
of 16.85%. Headquartered in Cincinnati, Ohio, Chemed operates primarily through 
its VITAS and Roto-Rooter segments, offering a wide range of services from hospice
and palliative care to commercial and residential plumbing solutions.

As of the latest trading session, Chemed’s stock is priced at $475.41, reflecting
a modest increase of 0.01%. The stock’s 52-week range showcases a low of $412.30
and a high of $619.21, indicating a significant volatility that investors must consider.
However, with a market capitalization of $6.93 billion, Chemed remains a substantial
player in the medical care facilities industry.

###Valuation and Performance Insights

Chemed’s forward P/E ratio stands at 18.71, suggesting a reasonable valuation relative
to its future earnings potential, even as traditional valuation metrics like P/E
and PEG ratios are not available. The company’s return on equity is an impressive
24.11%, underscoring its efficiency in generating profits from shareholders’ equity.
Additionally, Chemed’s free cash flow of $278.54 million highlights its strong cash
generation capability, a vital metric for sustaining operations and potential growth
investments.

The company’s revenue growth at 3.10% aligns with steady operational performance,
while its earnings per share (EPS) is reported at 18.92. Despite the absence of 
net income data, the EPS figure offers a glimpse into the company’s profitability
on a per-share basis.

###Dividend and Analyst Outlook

Chemed offers a dividend yield of 0.48% with a conservative payout ratio of 11.11%,
reflecting a strategy of reinvesting earnings into the business while providing 
steady returns to shareholders. This balance appeals to investors seeking growth
with a modest income component.

Analysts present a favorable outlook for Chemed, with three buy ratings and one 
hold rating. No sell ratings have been recorded, pointing to a general consensus
of confidence in the company’s future prospects. The analyst target price range 
of $475.00 to $595.00, with an average target of $555.50, suggests a significant
potential upside for investors willing to bet on Chemed’s continued success.

###Technical Analysis

Technical indicators paint an intriguing picture for Chemed. The stock’s 50-day 
moving average of $443.09 and 200-day moving average of $467.19 suggest a bullish
trend, with the current price exceeding both averages. The relative strength index(
RSI) stands at 73.75, indicating that the stock is potentially overbought, which
could signal a forthcoming price correction. Meanwhile, the MACD of 8.68, above 
the signal line of 5.92, further supports the bullish sentiment.

###Conclusion

Chemed Corp’s diversified operations in healthcare and plumbing services position
it as a resilient entity within the industry. While investors should be aware of
potential volatility, the company’s strong cash flow, impressive return on equity,
and analyst confidence provide a compelling case for future growth. With a potential
upside of 16.85%, Chemed offers an attractive opportunity for investors seeking 
exposure to both the healthcare and essential services sectors. As with any investment,
due diligence and consideration of market conditions are advised.

Share on: